Offering international quality standards to the Cannabis Industry with our purified cannabis concentrates.
MediPharm Labs Corp. and Emerald Health Therapeutics, Inc. Sign Cannabis Concentrate Program Agreement
Extracting cannabis for beverage and edibles
Leaders in the Cannabis industry, our quality-focused team drives innovation through research, discipline, and collaboration.
A leader in cannabis extraction and purification, MediPharm Labs has invested in an expert team, state-of-the-art technology, advanced methodologies and a purpose-built facility to deliver pure, safe and precisely-dosed cannabis concentrates and advanced derivative products.
MediPharm is a unique Licensed Producer with a singular focus on extraction and purification. This specialization drives leadership.
Our research-driven team has deep bio-pharmaceutical experience, led by a renowned chromatography expert.
Our cGMP and ISO standard of design and construction are currently the most innovative and technically advanced in the Canadian cannabis industry.
Since June of 2018, MediPharm Labs has been producing purified cannabis concentrates with proven technology and proprietary methodologies.
Cannabis 2.0 will be dominated by advanced derivative products. MediPharm is aligning with strategic partners and research institutions globally to meet consumer demand.
MediPharm Labs has a future as a connector in the cannabis industry, linking Licensed Producers with derivative product Manufacturers and Retailers through expert extraction, purification, product formulation, and processing. In March 2018, our company received our cannabis oil production license from Health Canada and have been extracting here in Ontario since June 2018. We anticipate receiving our Health Canada Cannabis Sales License during the fall of 2018.
MediPharm Labs has also launched in Australia, and pending Office of Drug Control Australia approval, will soon be producing cannabis oil. We are now taking enquiries for contract processing services and white label solutions. Be sure to check this page regularly as we add additional services in the exciting times ahead.
Oct 10, 2018
Oct 4, 2018
MediPharm Labs Corp. (TSXV: LABS) (Formerly POCML 4 Inc.) Provides Corporate Update Upon Commencement of Trading on the TSXV
MediPharm Labs is built on the foundation of a strong executive team, with professionals from complementary industries that include global pharmaceuticals, healthcare, energy, and biotechnology manufacturing.
The Board of Directors of MediPharm Labs Corp. is fully committed to our stakeholders and shareholders, providing oversight, governance and leadership to provide stability and growth over the long term.